Literature DB >> 3036223

Optimal posttranslational translocation of the precursor of PhoE protein across Escherichia coli membrane vesicles requires both ATP and the protonmotive force.

T De Vrije, J Tommassen, B De Kruijff.   

Abstract

In order to reach their final destination, periplasmic and outer membrane proteins have to pass the cytoplasmic membrane of Escherichia coli cells. To study the transport of PhoE protein, we developed an in vitro transcription-translation and translocation system. In this in vitro system, the protein is synthesized as a larger precursor, which can be processed by purified leader peptidase. The precursor can be translocated into inverted inner membrane vesicles as judged by the protection against externally added protease. Only part of the translocated protein is in the processed mature form. Translocation can occur posttranslationally and requires both ATP and the protonmotive force for an optimal process. Upon incubation of vesicles with mature PhoE protein or precursor PhoE in the absence of ATP, the proteins are bound to the vesicles, but they are not translocated, since they are still sensitive to externally added protease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036223     DOI: 10.1016/0005-2736(87)90278-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  35 in total

1.  Efficient membrane assembly of the KcsA potassium channel in Escherichia coli requires the protonmotive force.

Authors:  A van Dalen; H Schrempf; J A Killian; B de Kruijff
Journal:  EMBO Rep       Date:  2000-10       Impact factor: 8.807

2.  The SurA periplasmic PPIase lacking its parvulin domains functions in vivo and has chaperone activity.

Authors:  S Behrens; R Maier; H de Cock; F X Schmid; C A Gross
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

3.  A conserved function of YidC in the biogenesis of respiratory chain complexes.

Authors:  M van der Laan; M L Urbanus; C M Ten Hagen-Jongman; N Nouwen; B Oudega; N Harms; A J M Driessen; J Luirink
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-30       Impact factor: 11.205

4.  Demonstration of a specific Escherichia coli SecY-signal peptide interaction.

Authors:  Ligong Wang; Alexander Miller; Sharyn L Rusch; Debra A Kendall
Journal:  Biochemistry       Date:  2004-10-19       Impact factor: 3.162

5.  Activators of the glutamate-dependent acid resistance system alleviate deleterious effects of YidC depletion in Escherichia coli.

Authors:  Zhong Yu; Martijn Bekker; Angela Tramonti; Gregory M Cook; Peter van Ulsen; Dirk-Jan Scheffers; Joost Teixeira de Mattos; Daniela De Biase; Joen Luirink
Journal:  J Bacteriol       Date:  2011-01-07       Impact factor: 3.490

6.  Processing and maturation of the pilin of the type IV secretion system encoded within the gonococcal genetic island.

Authors:  Samta Jain; Jörg Kahnt; Chris van der Does
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

7.  Trigger Factor can antagonize both SecB and DnaK/DnaJ chaperone functions in Escherichia coli.

Authors:  Ronald S Ullers; Debbie Ang; Françoise Schwager; Costa Georgopoulos; Pierre Genevaux
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

8.  Characterization of two genes, glpQ and ugpQ, encoding glycerophosphoryl diester phosphodiesterases of Escherichia coli.

Authors:  J Tommassen; K Eiglmeier; S T Cole; P Overduin; T J Larson; W Boos
Journal:  Mol Gen Genet       Date:  1991-04

9.  The conserved third transmembrane segment of YidC contacts nascent Escherichia coli inner membrane proteins.

Authors:  Zhong Yu; Gregory Koningstein; Ana Pop; Joen Luirink
Journal:  J Biol Chem       Date:  2008-10-06       Impact factor: 5.157

10.  PrlA4 prevents the rejection of signal sequence defective preproteins by stabilizing the SecA-SecY interaction during the initiation of translocation.

Authors:  J P van der Wolk; P Fekkes; A Boorsma; J L Huie; T J Silhavy; A J Driessen
Journal:  EMBO J       Date:  1998-07-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.